Rendering of Lilly's forthcoming manufacturing site in Alzey, Germany (Credit: Eli Lilly)

November 17, 2023 10:29 AM EST

Lilly invests $2.5B in new German site to boost tirzepatide supply, $100M for local biotechs

Anna Brown

News Reporter

Kyle LaHucik

Senior Reporter

Eli Lilly is set to build a new $2.5 billion facility in Germany to increase manufacturing capacity for its blockbuster diabetes and obesity drugs, and …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Lilly invests $2.5B in new German site to boost tirzepatide supply, $100M for local biotechs

Anna Brown

News Reporter

Kyle LaHucik

Senior Reporter

Sign up to read this article for free.

The Endpoints 2024 winners and losers list: Who was up and who was down in biopharma

CagriSema’s weight loss data disappointed. What does Novo do next?

Three drugmakers sue US over 340B discounts to STD clinics they allege don’t qualify

Deerfield wins fight to acquire Singular Genomics, beating out Tang Capital’s Concentra

CMS explains what went into its first round of drug price negotiations

FDA approves Lilly's Zepbound for sleep apnea, likely cracking open Medicare market

Lil­ly in­vests $2.5B in new Ger­man site to boost tirzepatide sup­ply, $100M for lo­cal biotechs

News Reporter

Senior Reporter

Sign up to read this article for free.

more like this

Lilly invests $2.5B in new German site to boost tirzepatide supply, $100M for local biotechs